Comparable stake leader
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
SEC ownership of IGC Pharma, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001326205.
Disclosed value leader
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
Comparable rows
0/43
Latest evidence
01 Apr 2026
- Public ticker
- IGC on NYSE
- Parsed ownership sources
- 3/4/5 and 13F
- Largest SEC-reported holder
- Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
- Latest parsed ownership date
- 01 Apr 2026
- Issuer CIK
- 0001326205
- Issuer location
- Potomac, MD
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of IGC Pharma, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bradbury Strategic Invest...
Disclosed value leader
Bradbury Strategic Invest...
Comparable rows
0/43
Latest evidence
01 Apr 2026
3/4/5
13F
Highest disclosed value: $4,700,000
43 rows are not safely comparable across share classes.
Showing 1-8 of 43 holder rows.
Quick read
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) has the largest disclosed position value at $4.7M.
0 of 43 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)'s linked filing trail.
Disclosed position value
Top 5
Bradbury Strategic Investment Fun...
$4.7M
Ram Mukunda
$1.56M
Richard K. Prins
$433.7K
Claudia Grimaldi
$386.3K
James P. Moran
$347.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 43 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$4,700,000
13,823,529 shares
|
— | 22 Mar 2024 |
| Ram Mukunda |
3/4/5
CEO, Director
|
—
mixed-class rows
|
$1,564,538
6,270,098 shares
mixed-class rows
|
— | 01 Apr 2026 |
| Richard K. Prins |
3/4/5
Director
|
—
mixed-class rows
|
$433,708
2,361,251 shares
mixed-class rows
|
— | 01 Apr 2026 |
| Claudia Grimaldi |
3/4/5
PFO, Director
|
—
mixed-class rows
|
$386,281
1,594,252 shares
mixed-class rows
|
— | 01 Apr 2026 |
| James P. Moran |
3/4/5
Director
|
—
mixed-class rows
|
$347,735
1,785,735 shares
mixed-class rows
|
— | 01 Apr 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$274,440
1,043,384 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$188,949
718,436 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
—
class O/S missing
|
$185,099
703,798 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 12 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-8 of 8 reporting-owner rows connected to IGC Pharma, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
8
Largest Forms 3/4/5 holder
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
Net 12M change
$0
Latest report
01 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) | 10%+ Owner | $4,700,000 | Mixed | 22 Mar 2024 | ||
| Ram Mukunda | CEO, Director | $1,564,538 | Mixed | 01 Apr 2026 | ||
| Richard K. Prins | Director | $433,708 | Mixed | 01 Apr 2026 | ||
| Claudia Grimaldi | PFO, Director | $386,281 | Mixed | 01 Apr 2026 | ||
| James P. Moran | Director | $347,735 | Mixed | 01 Apr 2026 | ||
| Rohit Goel | Senior Director of Finance&PAO | $79,900 | Mixed | 13 May 2021 | ||
| John E. Lynch | Director | $45,696 | Mixed | 31 May 2022 | ||
| Terry L. Lierman | Director | Mixed | 17 Oct 2025 |
Recent insider transactions for IGC Pharma, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Richard K. Prins | IGC | Common Stock | Options Exercise | 12.4% | 170,000 | 1,541,251 | 01 Apr 2026 | Direct | ||
| Richard K. Prins | IGC | Restricted Stock Units | Options Exercise | -100% | -170,000 | 0 | 01 Apr 2026 | Direct | ||
| Ram Mukunda | IGC | Common Stock | Options Exercise | 5.81% | 49,999 | 910,751 | 01 Apr 2026 | BY SPOUSE | ||
| Ram Mukunda | IGC | Common Stock | Options Exercise | 16.4% | 656,410 | 4,649,088 | 01 Apr 2026 | Direct | ||
| Ram Mukunda | IGC | Restricted Stock Units | Options Exercise | -100% | -49,999 | 0 | 01 Apr 2026 | BY SPOUSE | ||
| Ram Mukunda | IGC | Options | Options Exercise | -32.3% | -323,077 | 676,925 | 01 Apr 2026 | Direct | ||
| Ram Mukunda | IGC | Restricted Stock Units | Options Exercise | -100% | -333,333 | 0 | 01 Apr 2026 | Direct | ||
| James P. Moran | IGC | Common Stock | Options Exercise | 11.8% | 130,000 | 1,235,735 | 01 Apr 2026 | Direct | ||
| James P. Moran | IGC | Restricted Stock Units | Options Exercise | -100% | -130,000 | 0 | 01 Apr 2026 | Direct | ||
| Claudia Grimaldi | IGC | Common Stock | Options Exercise | 21% | 238,462 | 1,372,714 | 01 Apr 2026 | Direct | ||
| Claudia Grimaldi | IGC | Options | Options Exercise | -38.5% | -138,462 | 221,538 | 01 Apr 2026 | Direct | ||
| Claudia Grimaldi | IGC | Restricted Stock Units | Options Exercise | -100% | -100,000 | 0 | 01 Apr 2026 | Direct | ||
| Ram Mukunda | IGC | Common Stock | Options Exercise | 6.17% | 50,000 | 860,752 | 03 Feb 2026 | BY SPOUSE | ||
| Ram Mukunda | IGC | Restricted Stock Units | Award | 83,333 | 66,666 | 03 Feb 2026 | BY SPOUSE | |||
| Richard K. Prins | IGC | Common Stock | Options Exercise | 7.87% | 100,000 | 1,371,251 | 19 Jan 2026 | Direct | ||
| Richard K. Prins | IGC | Restricted Stock Units | Options Exercise | -66.7% | -100,000 | 50,000 | 19 Jan 2026 | Direct | ||
| Richard K. Prins | IGC | Options | Award | 750,000 | 750,000 | 17 Oct 2025 | Direct | |||
| James P. Moran | IGC | Options | Award | 500,000 | 500,000 | 17 Oct 2025 | Direct | |||
| Terry L. Lierman | IGC | Options | Award | 500,000 | 500,000 | 17 Oct 2025 | Direct | |||
| Claudia Grimaldi | IGC | Common Stock | Gift | -4.22% | -50,000 | 1,134,252 | 17 Oct 2025 | Direct | ||
| Claudia Grimaldi | IGC | Options | Award | 1,500,000 | 1,000,000 | 17 Oct 2025 | Direct | |||
| Ram Mukunda | IGC | Common Stock | Gift | -2.44% | -100,000 | 3,992,678 | 17 Oct 2025 | Direct | ||
| Ram Mukunda | IGC | Options | Award | 4,500,000 | 3,000,000 | 17 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.